Survey of Prescriptions for Peptic Ulcer Drugs (ACT Class AOB2) in Iceland

References

• Wyllie J H., Clark C G., Alexander Williams J, Bell P RF, Kennedy T L., Kirk R M., et al. Effect of cimetidine on surgery for duodenal ulcer. Lancet 1981; 1: 1307–8
   PubMed Web of Science ®Google Scholar
• Baron J H., Alexander Williams J, Beasnell J R. Cimetidine and duodenal ulcer. Br Med J 1979; 1: 169–73
   PubMed Web of Science ®Google Scholar
• Bardham K D., Hinchliffe R FC. Effect of cimetidine on surgery for duodenal ulcer. Lancet 1981; 2: 38
   PubMed Web of Science ®Google Scholar
• Penn I. The declining role of the surgeon in the treatment of acid peptic diseases. Arch Surg 1980; 115: 134–5
   PubMedGoogle Scholar
• Fineberg H V., Pearlmann L A. Surgical treatment of peptic ulcer in the United States. Trends before and after the introduction of cimetidine. Lancet 1981; 1: 1305–7
   PubMed Web of Science ®Google Scholar
• Tilvis R S., Vuoristo M, Varis K. Changed profile of peptic ulcer disease in hospital patients during 1969-1984 in Finland. Scand J Gastroenterol 1987; 22: 1238–44
   PubMed Web of Science ®Google Scholar
• Bardham K D., Cust G, Hinchliffe R CF, Williamson F M., Lyon C, Bose K. Changing pattern of admissions and operations for duodenal ulcer. Br J Surg 1989; 76: 230–6
   PubMed Web of Science ®Google Scholar
• Kurala J H., Honda G D., Frantel H. Hospitalization and mortality rates for peptic ulcer: a comparison of a large health maintenance organization and United States data. Gastroenterology 1982; 83: 1008–16
   PubMed Web of Science ®Google Scholar
• Makela J, Lattinen J, Kauruloma M I. Complications of peptic ulcer disease before and after the introduction of H2 receptor antagonists. Hepatogastroenterology 1992; 39: 144–8
   PubMedGoogle Scholar
• Christensen A, Bousfield R. Ulcuskirurgi för och efter indförelsen af H2 blokker behandlinger. Ugeskr Laeger 1987; 149/43: 2895–7
   Google Scholar
• Walt R, Katschinski B, Logan R, Ashley J, Langmann M. Rising frequency of ulcer perforation in elderly people in the United Kingdom. Lancet 1986; 1: 489–92
   PubMed Web of Science ®Google Scholar
• Hansen J M., Bytzer F, Muckadell O B. Ulcuskomplikationer i Fyns Amt i perioden 1980-1990. Ugeskr Laeeer 1991; 153/20: 1402–5
   Google Scholar
• Koo J, Ngan Y K., Lam S K. Trends in hospital admission, perforation and mortality of peptic ulcer in Hong Kona from 1970-1980. Gastroenterology 1983; 84: 1558–62
   PubMed Web of Science ®Google Scholar
• Penston J G., Wormsley K G. Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease. Aliment Pharmacol Ther 1992; 6: 629–45
   PubMed Web of Science ®Google Scholar
• Penston J G., Crombie I K., Waugh N R., Wormsley K G. Trends in morbidity and mortality from peptic ulcer disease. Tayside versus Scotland. Aliment Pharmacol Ther 1993; 7: 429–42
   PubMed Web of Science ®Google Scholar
• La Vecchia C, Lucchini F, Negri E, Reggi V, Levi F. The impact of therapeutic improvements in reducing peptic ulcer mortality in Europe. Int J Epidemiol 1993; 22: 96–106
   PubMed Web of Science ®Google Scholar
• 1990, Nordic Statistics on Medicines 1987–1989. NLN Publication; No 30:47
   Google Scholar
• Icelandic drug market. 2Q 1991. Dansk laeg-emiddelstatistik, Copenhagen 1991
   Google Scholar
• Thors H, Sigurdsson H, Oddsson E, Amthorsson G, Thjodleifsson B. Aògeròir viò ulcus pepticum à Íslandi 1971-1989 [abstract]. Læknablaòiò (The Icelandic Medical Journal) 1992; 62, (fylgirit 21)
   Google Scholar
• Thors H, Sigurdsson H, Oddsson E, Thjodleifsson B. Dánartíò af völdum ulcus pepticum à Íslandi 1950-1990 [abstract]. Læk-nablaòiò (The Icelandic Medical Journal) 1992; 63, (fylgirit 21)
   Google Scholar
• Dungal N, Hansen H, Schweiz Z. Peptic ulcers in Iceland. Path Bakt 1958; 21: 225–8
   PubMedGoogle Scholar
• Bonnevie O. Changing demographics of peptic ulcer disease. Dis Dis Sci 1985; 30(11 Suppl)85–145
   Web of Science ®Google Scholar
• Colin Jones D G., Bloom B, Bodemar G. The management of dyspepsia: report of a Working Party. Lancet 1988; 1: 576–9
   PubMed Web of Science ®Google Scholar
• Gudjónsson H, Oddsson E, Björnsson S, Gunnlaugsson G, Theodórs Á, Jónasson T Á, et al. Efficacy of sucralfate in the treatment of non-ulcer dyspepsia. A double-blind placebo controlled study. Scand J Gastroenterol 1993; 28: 969–72
   PubMed Web of Science ®Google Scholar
• Möller H, Nissen A, Mosbech J. Use of cimetidine and other peptic drugs in Denmark 1977-1990 with analysis of the risk of gastric cancer among cimetidine users. Gut 1992; 33: 1166–9
   PubMed Web of Science ®Google Scholar
• Nyren O, Adami H O., Gustafson S, Lööf L, Nyberg A. Social and economic effects of non-ulcer dyspepsia. Scand J Gastroenterol 1985; 20(Suppl 109)41–5
   Google Scholar
• Veldhusen van Zanten S JO, Tytgat K MAJ, Jalali S, Goodacre R L., Hunt R H. Can gastritis symptoms be evaluated in clinical trials? An overview of treatment of gastritis, non-ulcer dyspepsia and Camphylobacter-associated gastritis. J Clin Gastroenterol 1989; 11: 496–501
   PubMed Web of Science ®Google Scholar
• Lööf L, Adami H O., Agenäs I, Gustafsson S, Nyberg A, Nyren O. The diagnosis and therapy survey October 1978-March 1983, health care consumption and current drug therapy in Sweden with respect of the clinical diagnosis of gastritis. Scand J Gastroenterol 1985; 20(Suppl 109)35–9
   Google Scholar
• Kelbæk H, Linde J, Eriksen J, Munkgaard S, Mosegaard F, Bonnevie O. Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia. Acta Med Scand 1985; 217: 281–7
   PubMed Web of Science ®Google Scholar
• Gormsen M, Jensen K S., Matsen P, Bonnevie O. Grundlaget for anvendelse af ulcusmedicin i almen praksis. Ugeskr Læger 1988; 150: 2169–71
   PubMedGoogle Scholar
• Schade R, Donaldsen R M. How physicians use cimetidine. N Engl J Med 1981; 304: 1281–4
   PubMed Web of Science ®Google Scholar
• Heatley R V., Rathbone B J. Dyspepsia: a dilemma for doctors?. Lancet 1987; 2: 779–81
   PubMed Web of Science ®Google Scholar
• Health and Public Policy Committee, American College of Physicians. Endoscopy in the evaluation of dyspepsia. Ann Intern Med 1985; 102: 266–9
   PubMed Web of Science ®Google Scholar
• Bytzer P, Hansen J M., Schaffalitzky de Muckadell O. Overforsel af patent ulcusmedicin til handkob. Ugeskr Læger 1991; 153: 1405–10
   PubMedGoogle Scholar
• Oddsson E, Binder V, Thorgeirsson T, Jónasson T Á, Gunnlaugsson O, Wulff M, et al. A prospective comparative study of clinical and pathological characteristics in Icelandic and Danish patients with gastric ulcer, duodenal ulcer and X-ray negative dyspepsia. II. Histological results. Scand J Gastroenterol 1978; 13: 489–95
   PubMed Web of Science ®Google Scholar
• Hedley A J., Thjodleifsson B, Donald D, Swanson Beck J, Crooks J, Chesters M I., et al. Thyroid function in normal subjects in Iceland and Northeast Scotland. Clin Endocr 1977; 7: 377–82
   PubMed Web of Science ®Google Scholar
• Kristinsson K, Thjodleifsson B, Sigvaldadóttir E, Jensson Ö, Wadström T. Mælingar à mótefnum gegn Helicobacter pylori hjá Íslendingum [abstract]. Læknablaòiò (The Icelandic Medical Journal) 1992; 78((Fylgirit 21))60
   Google Scholar
• Tulinius H, Storm H H., Pukkala E, Andersen A, Ericsson J. Cancer in the Nordic countries, 1981-86. APMIS 1992; 100(Suppl 31)53
   Google Scholar
• Stemmermann G N. The role of Helicobacter pylori in the etiology of gastric cancer. Cancer prevention, V T. DeVita, et al. Lippincott, Philadelphia 1991; 53
   Google Scholar
• Greenberg R E., Bank S. The prevalence of Helicobacter pylori in non-ulcer dyspepsia. Importance of stratification according to age. Arch Intern Med 1990; 150: 2053–5
   PubMedGoogle Scholar
• Rokkas T, Pursey C, Uzoechino E, et al. Campylobacter pylori and non-ulcer dyspepsia. Am J Gastroenterol 1987; 82: 1149–52
   PubMed Web of Science ®Google Scholar
• Ólafsson ó. Streita, vinna og heilsa í velferòarpjóòfélagi. Heilbrigòisskýrslur 1989, Fylgirit 4. Landlæknisembættiò, Reykjavík 1989, (Public Health in Iceland–with an English summary)
   Google Scholar